Looking to cure Type 1 diabetes

Beyond Biotech - the podcast from Labiotech

Conteúdo fornecido por Labiotech. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por Labiotech ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.

5M ago 23:40

MP3•Home de episódios

Diamyd Medical develops precision medicine therapies for the prevention and treatment of Type 1 diabetes and LADA (latent autoimmune diabetes in adults).

Diamyd is an antigen-specific immunomodulatory therapeutic for the preservation of endogenous insulin production. It has been granted Orphan Drug Designation in the U.S. as well as Fast Track Designation.

DIAGNODE-3, a confirmatory phase 3 trial, uses injections into a superficial lymph node can to optimize the treatment response.

This week on the podcast we have a conversation about treatments of type 1 diabetes, including the company’s development of Diamyd. Our guest is Anders Essen-Möller, founder and chairman of Diamyd Medical.

00:51-19:16: Diamyd Medical’s approach to Type 1 diabetes
19:16-21:03: Other approaches to tackling Type 1 diabetes
21:03-22:08: Keeping costs of Type 1 diabetes treatment low
22:08-22:53: Can Type 1 diabetes be cured?
Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here!

Stay updated by subscribing to our newsletter

Capítulos

1. Looking to cure Type 1 diabetes (00:00:00)

2. Diamyd Medical’s approach to tackling Type 1 diabetes (00:00:51)

3. Other approaches to tackling Type 1 diabetes (00:19:16)

4. eeping costs of Type 1 diabetes treatment low  (00:21:03)

5. Can Type 1 diabetes be cured? (00:22:08)

123 episódios

#News #Tech News #Labiotech